Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro

Authors: D'Antuono, Margherita¹; Köhling, Rüdiger²; Ricalzone, Serena¹; Gotman, Jean¹; Biagini, Giuseppe³; Avoli, Massimo

Source: Epilepsia, Volume 51, Number 3, March 2010 , pp. 423-431(9)

Publisher: Wiley-Blackwell

Abstract:

Summary Purpose: 

We established the effects of the antiepileptic drugs (AEDs) carbamazepine (CBZ), topiramate (TPM), and valproic acid (VPA) on the epileptiform activity induced by 4-aminopyridine (4AP) in the rat entorhinal cortex (EC) in an in vitro brain slice preparation. Methods: 

Brain slices were obtained from Sprague-Dawley rats (200-250 g). Field and intracellular recordings were made from the EC during bath application of 4AP (50 μm). AEDs, and in some experiments, picrotoxin were bath applied concomitantly. Results: 

Prolonged (>3 s), ictal-like epileptiform events were abolished by CBZ (50 μm), TPM (50 μm), and VPA (1 mm), whereas shorter (<3 s) interictal-like discharges continued to occur, even at concentrations up to 4-fold as high. γ-Aminobutyric acid (GABA)_A-receptor antagonism changed the 4AP-induced activity into recurrent interictal-like events that were not affected by CBZ or TPM, even at the highest concentrations. To establish whether these findings reflected the temporal features of the epileptiform discharges, we tested CBZ and TPM on 4AP-induced epileptiform activity driven by stimuli delivered at 100-, 10-, and 5-s intervals; these AEDs reduced ictal-like responses to stimuli at 100-s intervals at nearly therapeutic concentrations, but did not influence shorter interictal-like events elicited by stimuli delivered every 10 or 5 s. Conclusions: 

We conclude that the AED ability to control epileptiform synchronization in vitro depends mainly on activity-dependent characteristics such as discharge duration. Our data are in keeping with clinical evidence indicating that interictal activity is unaffected by AED levels that are effective to stop seizures.

Keywords: Antiepileptic drugs; 4-Aminopyridine; Entorhinal Cortex; Epilepsy; Hippocampus; Picrotoxin

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1528-1167.2009.02273.x

Affiliations: 1: Montreal Neurological Institute and Departments of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada 2: Institute of Physiology, University of Rostock, Rostock, Germany 3: Dipartimento di Scienze Biomediche, Università di Modena e Reggio Emilia, Modena, Italy

Publication date: 2010-03-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Neurology & Psychiatry
• By this author: D'Antuono, Margherita ;  Köhling, Rüdiger ;  Ricalzone, Serena ;  Gotman, Jean ;  Biagini, Giuseppe ;  Avoli, Massimo

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers